interleukins (IL) and meta-analysis Archives

Abstract Number: 237 • ACR/ARHP Annual Meeting 2018
The Risk of Serious and Opportunistic Infections in Rheumatologic Patients on Interleukin Inhibitors: A Systematic Review and Meta-Analysis
Adam Berlinberg¹, Jawad Bilal², Abdullah Alhifany³, Warda Faridi⁴ and C. Kent Kwoh⁵, ¹Department of Internal Medicine, University of Arizona, Tucson, AZ, ²Internal Medicine, University of Arizona, Tucson, AZ, ³Department of Pharmacy, University of Arizona, Tucson, AZ, ⁴Department of Hematology/Oncology, University of Arizona, Tucson, AZ, ⁵Medicine, Division of Rheumatology, University of Arizona School of Medicine, University of Arizona Arthritis Center, Tucson, AZ
Background/Purpose: Interleukin (IL) inhibitors are increasingly being used for rheumatologic diseases. There are many controlled clinical trials assessing the efficacy of IL inhibitors, but there…

Abstracts tagged "interleukins (IL) and meta-analysis"